Inventor · disambiguated record
Rachel Schneerson
Also filed as: SCHNEERSON RACHEL
27 granted patents·9 pending applications·243 citations·filing 1988–2016
95Inventor score
Files withUS HEALTH22KUBLER-KIELB JOANNA2LEPPLA STEPHEN H2SCHNEERSON RACHEL2US GOV HEALTH & HUMAN SERV2
Top patents by PatentIndex Score
36 records- 0185US8444996B2Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodiaSCHNEERSON RACHEL·Filed 2009·Granted May 21, 2013·12 cites·16 claims
- 0284US9096653B2Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodiaUS HEALTH·Filed 2013·Granted Aug 4, 2015·8 cites·12 claims
- 0384US7754227B2Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccineUS HEALTH·Filed 2007·Granted Jul 13, 2010·2 cites·15 claims
- 0484US7261900B2Recombinant modified Bacillus anthracis protective antigen for use in vaccinesUS HEALTH·Filed 2003·Granted Aug 28, 2007·15 cites·13 claims
- 0584US5204098APolysaccharide-protein conjugatesUS HEALTH·Filed 1988·Granted Apr 20, 1993·72 cites·18 claims
- 0683US8383133B2Conjugates of Plasmodium falciparum surface proteins as malaria vaccinesUS HEALTH·Filed 2007·Granted Feb 26, 2013·2 cites·6 claims
- 0781US8481048B2Methods for preparing immunogenic conjugatesSCHNEERSON RACHEL·Filed 2009·Granted Jul 9, 2013·2 cites·16 claims
- 0880US7422755B2Antimultiorganism glycoconjugate vaccineUS HEALTH·Filed 2005·Granted Sep 9, 2008·3 cites·5 claims
- 0979US8394387B1Recombinant modified Bacillus anthracis protective antigen for use in vaccinesLEPPLA STEPHEN H·Filed 2007·Granted Mar 12, 2013·2 cites·13 claims
- 1078US5445817APertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccinesUS HEALTH·Filed 1992·Granted Aug 29, 1995·66 cites·11 claims
- 1177US8202520B2Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccineKOSSACZKA ZUZANA·Filed 2010·Granted Jun 19, 2012·2 cites·10 claims
- 1277US8044189B2Bacillus anthracis protective antigen nucleic acid sequencesUS HEALTH·Filed 2010·Granted Oct 25, 2011·1 cites·8 claims
- 1373US8703150B2Methods of using Bacillus anthracis protective antigen sequences for vaccinationLEPPLA STEPHEN H·Filed 2011·Granted Apr 22, 2014·1 cites·10 claims
- 1473US8658180B2Vaccines against influenza virusMILLER MARK A·Filed 2009·Granted Feb 25, 2014·0 cites·22 claims
- 1572US6632437B1Immunogenic polysaccharide-protein conjugates containing poly α(2→8), α(2→9) NeuNAc capsular polysaccharidesUS HEALTH·Filed 1993·Granted Oct 14, 2003·47 cites·38 claims
- 1670US7803386B2Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilliUS HEALTH·Filed 2004·Granted Sep 28, 2010·5 cites·42 claims
- 1769US7763451B2Methods for preparing Bacillus anthracis protective antigen for use in vaccinesUS HEALTH·Filed 2002·Granted Jul 27, 2010·2 cites·30 claims
- 1869US2015093412A1Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthraxUS HEALTH·Filed 2014·Application pending·0 cites
- 1968US2010062023A1Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferiUS GOV HEALTH & HUMAN SERV·Filed 2009·Application pending·0 cites
- 2067US9144604B2Vaccine for ShigellaUS HEALTH·Filed 2014·Granted Sep 29, 2015·0 cites·12 claims
- 2167US8795680B2Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acidKUBLER-KIELB JOANNA·Filed 2007·Granted Aug 5, 2014·1 cites·16 claims
- 2267US8747863B2Vaccine for shigellaROBBINS JOHN B·Filed 2009·Granted Jun 10, 2014·0 cites·19 claims
- 2366US8501182B2Monoclonal antibodies that react with the capsule of Bacillus anthracisCHEN ZHAOCHUN·Filed 2009·Granted Aug 6, 2013·0 cites·29 claims
- 2466US2010330074A1Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthraxKUBLER-KIELB JOANNA·Filed 2009·Application pending·0 cites
- 2565US9273124B2Monoclonal antibodies that react with the capsule of Bacillus anthracisUS HEALTH·Filed 2013·Granted Mar 1, 2016·0 cites·15 claims
- 2665US8900599B2Conjugates of Plasmodium falciparum surface proteins as malaria vaccinesUS HEALTH·Filed 2013·Granted Dec 2, 2014·0 cites·6 claims
- 2765US7625736B2Methods for preparing immunogenic conjugatesUS HEALTH·Filed 2004·Granted Dec 1, 2009·0 cites·14 claims
- 2864US2004223973A1Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccineUS GOV HEALTH & HUMAN SERV·Filed 2004·Application pending·0 cites
- 2961US8926986B2Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthraxUS HEALTH·Filed 2013·Granted Jan 6, 2015·0 cites·4 claims
- 3060US7666846B2Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferiUS HEALTH·Filed 2004·Granted Feb 23, 2010·0 cites·12 claims
- 3160US2015050314A1Conjugates of plasmodium falciparum surface proteins as malaria vaccinesUS SECRETARY DEPT OF HEALTH AND HUMAN SERVICE·Filed 2014·Application pending·0 cites
- 3257US9845350B2Monoclonal antibodies that react with the capsule of bacillus anthracisUS HEALTH·Filed 2016·Granted Dec 19, 2017·0 cites·26 claims
- 3357US2014378669A1Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acidUS HEALTH·Filed 2014·Application pending·0 cites
- 3454US2014205622A1Vaccines against influenza virusUS HEALTH·Filed 2014·Application pending·0 cites
- 3547US2005202042A1Recombinant toxin A and toxin B protein carrier for polysaccharide conjugate vaccinesFiled 2004·Application pending·0 cites
- 3646US2014234360A1Influenza vaccineUS HEALTH·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →